TopoTarget HDAC Bull's Eye: 'Spectrum' of Benefit Ahead? | TopoTarget A/S' positive results from the BELIEF pivotal trial with belinostat could mean upside for Spectrum Pharmaceuticals Inc., if the histone deacetylase (HDAC) inhibitor is approved for peripheral T-cell lymphoma. The latest outcome with belinostat is "not really a game changer for this drug," said Lisa Murch. Find out the details. | | - Vanderbilt and Bristol team up for Parkinson's drugs
Bristol-Myers Squibb will work with Vanderbilt University on the discovery and development of treatments for Parkinson's disease. The Vanderbilt Center for Neuroscience Drug Discovery will seek candidates that target the mGluR4 glutamate receptor. Bristol will have the development and marketing rights to drugs arising from the collaboration. The focus will be on potential therapies from a program supported by The Michael J. Fox Foundation for Parkinson's Research. Pharmaceutical Business Review Online (9/24) | Built for a new generation of healthcare executives, the online MS in Health Care Administration at Saint Joseph's University offers a research-based curriculum delivered by professors with real-world experience from every corner of the healthcare industry. Specializations available in Health Care Ethics or Informatics. |
Company & Financial News | | | | - Venture capitalists return to biotechnology, life sciences
Venture-backed investments in biotechnology rose by 24% to $4.82 billion last year over 2010 figures, and venture firms are raising more funds this year dedicated to life sciences, biotech and medicine. Established drugmakers seeking refilled pipelines are increasingly investing in early-stage research, and some have set up their own venture funds. Regulations and policies that speed drug approvals could also accelerate returns and attract more funds, investors say. Reuters (9/24) Food & Agriculture | | | | - BGI and Gates Foundation partner to improve health and agriculture
The Bill & Melinda Gates Foundation signed a memorandum of understanding with BGI to collaborate on genomics projects aimed at enhancing agricultural development and health outcomes in developing countries. "We are confident that the combination of our respective capabilities, expertise and experience will yield important scientific breakthroughs in the areas of human, plant and animal genomics that will contribute to the advancement of sustainable health and agriculture development, especially in the developing world," said BGI chairman and co-founder Huanming Yang. GenomeWeb Daily News (free registration) (9/25) Industrial & Environmental | | | | - Algae.Tec aims to secure $600M in new funding for expansion plans
Algae.Tec is aiming to sign new supply agreements and secure as much as $600 million in new financing that would enable it to develop as many as six production facilities in four countries, including the U.S., by 2015. "We will be using different project finance structures for all of these projects, and they'll all be roughly $100 million," Executive Chairman Roger Stroud said. Bloomberg Businessweek (9/24) | | | | The Buzz(CORPORATE ANNOUNCEMENTS) | | | | | News from BIO | | | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program. SmartQuote | | | | | Worry does not empty tomorrow of its sorrow; it empties today of its strength." --Corrie ten Boom, Dutch writer | | | This SmartBrief was created for jmabs1@gmail.com | | Read more at SmartBrief.com | A powerful website for SmartBrief readers including: | | | | | | Recent BIO SmartBrief Issues: - Tuesday, September 25, 2012
- Monday, September 24, 2012
- Friday, September 21, 2012
- Thursday, September 20, 2012
- Wednesday, September 19, 2012
| | | Lead Editor: Tom Parks Mailing Address: SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | © 1999-2012 SmartBrief, Inc.® Legal Information | |
No comments:
Post a Comment